Abstract:Abstract Introduction: Hepatocellular Carcinoma (HCC) is a highly malignant and challenging-to-treat tumor, with early recurrence affecting up to 35-50% of patients within two years after surgery, significantly impacting prognosis. Identifying high-risk patients for recurrence is critical for guiding postoperative adjuvant therapy. The rapidly advancing field of single-cell RNA sequencing technology offers an unprecedented opportunity to discover clinically relevant cell subpopulations. Here, we harnessed single-cell techniques to unveil a cell subpopulation closely linked with HCC recurrence, highlighting its clinical significance. Methods and Results: We conducted single-cell RNA sequencing on four HCC samples and harmonized data from three public datasets (GSE112271, GSE125449, CNP0000650) to elucidate the heterogeneity of malignant cells in HCC. Our investigation revealed a distinctive HCC subpopulation enriched in patients with early recurrence (11.4% vs. 3.8%, P=0.02). This subpopulation exhibited up-regulated STMN1 and EZH2, signifying high proliferative potential and a propensity for epithelial-mesenchymal transition (EMT). Applying the CIBERSORTx algorithm to the TCGA-LIHC dataset (N=323 patients), we inferred the proportion of this recurrence subpopulation among all malignant cells. Notably, patients with a higher proportion of this subpopulation (N=160) demonstrated significantly shorter recurrence-free survival (31.2 vs. 42.9 months, P=0.002), reduced median survival (45.9 vs 55.7 months, P=0.03) and a higher rate of microvascular invasion (35% vs. 23%, P=0.01). To validate this recurrence-related subpopulation in clinical samples, we conducted multiplex immunohistochemistry staining on paraffin-embedded (FFPE) HCC samples (including CD45, CD31, ARG1, STMN1, EZH2) and used machine learning for its identification. Our findings revealed that patients with a higher proportion of this recurrence subpopulation (N=40) experienced significantly shorter median survival (38.5 vs. 51.0 months, P<0.005) and progression-free survival (25.1 vs. 33.4 months, P=0.01) compared to a lower proportion (N=40). Multivariate Cox regression analysis confirmed that the proportion of this recurrence subpopulation is an independent predictor of worse prognosis (P=0.003). Conclusion: Through the power of single-cell RNA sequencing technology, we have unearthed and characterized a malignant cell subpopulation intricately connected with HCC recurrence. Importantly, this subpopulation can be identified in FFPE tissue samples and correlates robustly with patient prognosis. Our study underscores the transformative possibility of single-cell techniques in developing cell subpopulation-based biomarkers, emphasizing their clinical relevance and potential utility in guiding postoperative adjuvant therapy for HCC patients. Citation Format: Yucheng Dong, Xin Guo, Xuezhu Wang, Fan Yang, Yongchang Zheng, Yang Chen. Single-cell sequencing identification of malignant cell subpopulations linked to recurrence in hepatocellular carcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 865.

High-throughput Single-cell CNV Detection Reveals Clonal Evolution During Hepatocellular Carcinoma Recurrence

Scdpn for High-throughput Single-cell CNV Detection to Uncover Clonal Evolution During HCC Recurrence

Abstract 3519: High-throughput Unbiased Microwell-Based Single-Cell CNV Detection Reveals Tumor Clonal Subtypes in Hepatocellular Carcinoma

A CNV Computational Model for Clonal Origin Analysis of Synchronous Multifocal Hepatobiliary and Pancreatic Tumors.

Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma

Single-cell and single-variant resolution analysis of clonal evolution in human liver cancer

Clonal Evolution in Long‐term Follow‐up Patients with Hepatocellular Carcinoma

Reproducible Copy Number Variation Patterns among Single Circulating Tumor Cells of Lung Cancer Patients

Single Cell Copy Number Variation Analysis of Circulating Tumor Cells in Gastrointestinal Cancer Patients for Study of Intra-Patient Genomic Heterogeneity.

Resolving clonal substructure from single cell genomic data using CopyKit

Longitudinal and Personalized Detection of Circulating Tumor DNA (ctdna) for Monitoring Efficacy of Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma (HCC).

Clonal evolution in liver cancer at single-cell and single-variant resolution

Clonecna: Detecting Subclonal Somatic Copy Number Alterations in Heterogeneous Tumor Samples from Whole-Exome Sequencing Data

Abstract 865: Single-cell sequencing identification of malignant cell subpopulations linked to recurrence in hepatocellular carcinoma

Multiple‐level copy number variations in cell‐free DNA for prognostic prediction of HCC with radical treatments

Circulating Tumor Dna Profiling Reveals Clonal Evolution And Real-Time Disease Progression In Advanced Hepatocellular Carcinoma

Technical And Clinical Validation Of Somatic Cnv Detection From Circulating Tumor Dna.

Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing

Single-cell sequencing deciphers a convergent evolution of copy number alterations from primary to circulating tumor cells.

IDDF2018-ABS-0097 Genomic heterogeneity and clonal evolution of multifocal hepatocellular carcinoma

Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma